Rate My Professor Mehdi Razavi

Dr. Mehdi Razavi is an Associate Professor of Medicine in the University of Central Florida College of Medicine and a member of the Biionix (Bionic Materials, Implants & Interfaces) Cluster. He was promoted to this position in 2024, having joined the University of Central Florida as an Assistant Professor in 2019. Since 2024, he holds secondary joint appointments in the Department of Materials Science and Engineering and the Biomedical Engineering program in the Department of Mechanical and Aerospace Engineering. Prior to his appointment at UCF, Dr. Razavi served as a Postdoctoral Research Fellow in Regenerative Medicine at Stanford University School of Medicine from 2016 to 2019. He was also a Postdoctoral Research Fellow in Biomaterials at the Brunel Centre for Advanced Solidification Technology within the Institute of Materials and Manufacturing and Brunel Institute for Bioengineering at Brunel University London from 2015 to 2016. Earlier, he worked as a Research Scholar in Biomaterials and Tissue Engineering at the School of Materials Science and Engineering, Helmerich Advanced Technology Research Center, Oklahoma State University from 2013 to 2014.

Dr. Razavi earned his BSc in Materials Engineering in 2008, MSc in Materials Engineering in 2011, and PhD in Biomaterials in 2014, all from Isfahan University of Technology. His research interests encompass biomaterials, nanomedicine, musculoskeletal tissue engineering and regenerative medicine, advanced biomanufacturing, drug and gene delivery systems, metal implants, tissue engineering and regenerative medicine, stem cells, orthopedic implants and bone scaffolds, cancer nanotechnology, pancreatic islet transplantation, and focused ultrasound therapy. He teaches nanomedicine, biomaterials, advanced materials, and research methodology in medicine. In 2022, Dr. Razavi received the NSF Faculty Early Career Development (CAREER) Program award amounting to $606,413 to support research aimed at developing bioabsorbable magnesium implants with enhanced corrosion resistance for reducing pain associated with bone fractures. Key publications include “Ultrasound-Responsive Nanobubbles for Combined siRNA-Cerium Oxide Nanoparticle Delivery to Bone Cells” (Pharmaceutics, 2023), “Bubble-Based Drug Delivery Systems: Next-Generation Diagnosis to Therapy” (Journal of Functional Biomaterials, 2023), and “An osteogenic magnesium alloy with improved corrosion resistance, antibacterial, and mechanical properties for orthopedic applications” (Journal of Biomedical Materials Research Part A, 2023). Dr. Razavi has served on various College of Medicine committees and Society for Biomaterials committees, acts as chief editor and editorial board member, and serves as a scientific reviewer for the NIH Study Section.